NCT03805477 Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation Status RECRUITING Phase PHASE2
NCT03717012 Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE4
NCT03710824 Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib Status COMPLETED Phase N/A
NCT03675581 A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Status COMPLETED Phase PHASE1
NCT03562416 Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects Status TERMINATED Phase PHASE2
NCT03513484 Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03377023 Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03363815 A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT03313180 A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis Status COMPLETED Phase PHASE3
NCT03292250 Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)] Status COMPLETED Phase PHASE2
NCT03287947 LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma Status TERMINATED Phase PHASE2
NCT03283007 Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2 Status COMPLETED Phase PHASE3
NCT03242759 Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan Status COMPLETED Phase N/A
NCT03047031 Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT02999178 Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Status COMPLETED Phase PHASE3
NCT02902484 Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02866370 Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium Status UNKNOWN Phase PHASE2
NCT02863055 Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma Status TERMINATED Phase PHASE2
NCT02856867 Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN) Status WITHDRAWN Phase PHASE2